Zhejiang Jianfeng Group's subsidiary, Jianfeng Pharmaceutical, passes drug GMP compliance inspection.
Peak Group (600668.SH) announced that its wholly-owned subsidiary, Zhejiang Peak Pharmaceutical Co., Ltd., recently obtained the announcement of the GMP compliance inspection results (Zhe 2025 No. 0254) from the Zhejiang Province Food and Drug Administration website. This time, the fluocinolone acetonide active pharmaceutical ingredient production line of Peak Pharmaceutical passed the GMP compliance inspection, obtained the capability to supply raw materials for the drug, ensuring the production of fluocinolone acetonide eye drops, further enriching the company's product line.
Zhejiang Jianfeng Group (600668.SH) announced that its wholly-owned subsidiary Zhejiang Jianfeng Pharmaceutical Co., Ltd. (referred to as "Jianfeng Pharmaceutical") recently received the announcement of the GMP compliance inspection results from the Zhejiang Provincial Drug Administration Agency (Zhejiang 2025 No. 0254) on their website. This time, Jianfeng Pharmaceutical's line for the production of Tofucinol raw materials passed the GMP compliance inspection, demonstrating its capability to supply raw materials for this drug, ensuring the production of Tofucinol eye drops, and further enriching the company's product line.
Related Articles
Subsidiary of Luoyang Jianlon Micro-Nano New Material Co., Ltd (688357.SH) plans to acquire 40% equity of Hanxing Energy for 200 million yuan.
RUICHANG INTL(01334): Guo Haiyang Appointed as Joint Company Secretary
Shaanxi Construction Machinery (600984.SH) terminates the issuance of shares to specific parties.
Subsidiary of Luoyang Jianlon Micro-Nano New Material Co., Ltd (688357.SH) plans to acquire 40% equity of Hanxing Energy for 200 million yuan.
RUICHANG INTL(01334): Guo Haiyang Appointed as Joint Company Secretary
Shaanxi Construction Machinery (600984.SH) terminates the issuance of shares to specific parties.
RECOMMEND
